Stock 6190 PHOENIXBIO CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart PhoenixBio Co., Ltd.

Equities

6190

JP3803010002

Delayed Japan Exchange
Other stock markets
 03:25:27 27/06/2024 BST 		5-day change 1st Jan Change
500 JPY -2.53% Intraday chart for PhoenixBio Co., Ltd. +2.88% +7.30%
2023 PhoenixBio Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023 CI
2022 PhoenixBio Co., Ltd. announced that it expects to receive ¥1.92 million in funding from Milestone Capital Management Co., Ltd. CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
PHOENIXBIO CO., LTD. Stock PhoenixBio Co., Ltd.
 12.31M - - - - -
MODERNA, INC. Stock Moderna, Inc.
 52.73B -
LONZA GROUP AG Stock Lonza Group AG
 39B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 38.52B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
 30.38B -
CELLTRION, INC. Stock Celltrion, Inc.
 26.39B
  1. Stock Market
  2. Equities
  3. 6190 Stock
  4. Charts PhoenixBio Co., Ltd.
  5. Sector Chart